Tavy Rosner
Stock Analyst at Barclays
(1.70)
# 3,409
Out of 5,090 analysts
58
Total ratings
31.11%
Success rate
-9.07%
Average return
Main Sectors:
Stocks Rated by Tavy Rosner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NICE NICE Ltd. | Maintains: Overweight | $200 → $165 | $106.20 | +55.37% | 12 | Nov 19, 2025 | |
| CEVA CEVA, Inc. | Maintains: Overweight | $30 → $35 | $23.00 | +52.17% | 10 | Nov 12, 2025 | |
| TSEM Tower Semiconductor | Maintains: Equal-Weight | $74 → $97 | $114.01 | -14.92% | 2 | Nov 11, 2025 | |
| KRNT Kornit Digital | Maintains: Equal-Weight | $22 → $18 | $14.00 | +28.57% | 8 | Nov 6, 2025 | |
| MGIC Magic Software Enterprises | Maintains: Overweight | $16 → $18 | $25.15 | -28.43% | 5 | Aug 13, 2025 | |
| RDWR Radware | Maintains: Overweight | $30 → $35 | $23.75 | +47.37% | 7 | Jul 31, 2025 | |
| SPNS Sapiens International Corporation | Maintains: Underweight | $28 → $31 | $43.31 | -28.42% | 8 | May 9, 2025 | |
| ITRN Ituran Location and Control | Maintains: Overweight | $35 → $50 | $41.08 | +21.71% | 2 | Feb 27, 2025 | |
| DOX Amdocs | Maintains: Overweight | $113 → $111 | $77.07 | +44.02% | 4 | Nov 14, 2024 |
NICE Ltd.
Nov 19, 2025
Maintains: Overweight
Price Target: $200 → $165
Current: $106.20
Upside: +55.37%
CEVA, Inc.
Nov 12, 2025
Maintains: Overweight
Price Target: $30 → $35
Current: $23.00
Upside: +52.17%
Tower Semiconductor
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $74 → $97
Current: $114.01
Upside: -14.92%
Kornit Digital
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $22 → $18
Current: $14.00
Upside: +28.57%
Magic Software Enterprises
Aug 13, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $25.15
Upside: -28.43%
Radware
Jul 31, 2025
Maintains: Overweight
Price Target: $30 → $35
Current: $23.75
Upside: +47.37%
Sapiens International Corporation
May 9, 2025
Maintains: Underweight
Price Target: $28 → $31
Current: $43.31
Upside: -28.42%
Ituran Location and Control
Feb 27, 2025
Maintains: Overweight
Price Target: $35 → $50
Current: $41.08
Upside: +21.71%
Amdocs
Nov 14, 2024
Maintains: Overweight
Price Target: $113 → $111
Current: $77.07
Upside: +44.02%